Genovate Biotechnology Co., Ltd. (TPEX:4130)
Taiwan · Delayed Price · Currency is TWD 26.60
+0.75 (2.90%)
May 29, 2026, 1:30 PM CST
Genovate Biotechnology Market Cap
Genovate Biotechnology has a market cap or net worth of 3.03 billion as of May 29, 2026. Its market cap has increased by 31.71% in one year.
Market Cap
3.03B
Enterprise Value
1.92B
Revenue
471.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.60
Market Cap Chart
Since November 3, 2008, Genovate Biotechnology's market cap has increased from 664.80M to 3.03B, an increase of 355.14%. That is a compound annual growth rate of 9.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 3.03B | -3.97% |
| Dec 31, 2025 | 3.15B | 35.56% |
| Dec 31, 2024 | 2.32B | -20.11% |
| Dec 29, 2023 | 2.91B | -17.02% |
| Dec 30, 2022 | 3.51B | 31.05% |
| Dec 30, 2021 | 2.68B | -15.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGend Therapeutics | 3.20B |
| Shine-On BioMedical | 3.20B |
| SYN-TECH Chem. & Pharm. | 3.19B |
| Chunghwa Chemical Synthesis & Biotech | 3.07B |
| GlycoNex Incorporation | 2.98B |
| Apex Biotechnology | 2.94B |
| TWi Biotechnology | 2.83B |
| HeXun Biosciences | 2.79B |